GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (FRA:SZD) » Definitions » Cyclically Adjusted PB Ratio

Santen Pharmaceutical Co (FRA:SZD) Cyclically Adjusted PB Ratio : 2.15 (As of Jun. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Santen Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Santen Pharmaceutical Co's current share price is €9.60. Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €4.46. Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 2.15.

The historical rank and industry rank for Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:SZD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.43   Med: 2.87   Max: 4.36
Current: 2.16

During the past years, Santen Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 4.36. The lowest was 1.43. And the median was 2.87.

FRA:SZD's Cyclically Adjusted PB Ratio is ranked worse than
54.37% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs FRA:SZD: 2.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was €5.174. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.39 2.59 1.92 1.62 2.02

Santen Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 1.72 1.88 1.89 2.02

Competitive Comparison of Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=9.60/4.46
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Santen Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.174/107.2000*107.2000
=5.174

Current CPI (Mar. 2024) = 107.2000.

Santen Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.157 98.000 3.453
201409 3.291 98.500 3.582
201412 3.217 97.900 3.523
201503 3.933 97.900 4.307
201506 3.769 98.400 4.106
201509 4.496 98.500 4.893
201512 4.718 98.100 5.156
201603 4.992 97.900 5.466
201606 5.226 98.100 5.711
201609 5.390 98.000 5.896
201612 5.095 98.400 5.551
201703 5.201 98.100 5.683
201706 5.132 98.500 5.585
201709 5.034 98.800 5.462
201712 5.144 99.400 5.548
201803 5.373 99.200 5.806
201806 5.497 99.200 5.940
201809 5.689 99.900 6.105
201812 5.718 99.700 6.148
201903 5.804 99.700 6.241
201906 5.914 99.800 6.353
201909 6.211 100.100 6.652
201912 6.246 100.500 6.662
202003 6.374 100.300 6.812
202006 6.326 99.900 6.788
202009 6.361 99.900 6.826
202012 6.247 99.300 6.744
202103 5.995 99.900 6.433
202106 5.875 99.500 6.330
202109 6.168 100.100 6.605
202112 6.249 100.100 6.692
202203 6.456 101.100 6.846
202206 6.170 101.800 6.497
202209 5.635 103.100 5.859
202212 5.491 104.100 5.655
202303 5.470 104.400 5.617
202306 5.312 105.200 5.413
202309 5.305 106.200 5.355
202312 5.238 106.800 5.258
202403 5.174 107.200 5.174

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Santen Pharmaceutical Co  (FRA:SZD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (FRA:SZD) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (FRA:SZD) Headlines

No Headlines